Continuing Education Company 19th Annual Primary Care Spring Conference 2025

Continuing Education Company 19th Annual Primary Care Spring Conference 2025

$100.00
Skip to product information
Continuing Education Company 19th Annual Primary Care Spring Conference 2025
  • Continuing Education Company 19th Annual Primary Care Spring Conference 2025
  • Continuing Education Company 19th Annual Primary Care Spring Conference 2025
Continuing Education Company 19th Annual Primary Care Spring Conference 2025

Continuing Education Company 19th Annual Primary Care Spring Conference 2025

$100.00

CEC 19th Annual Primary Care Spring Conference 2025

Continuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I | Internal Medicine, Family Medicine, Hepatology, Infectious Diseases, Women's Health, Cardiology, Psychiatry, Gastroenterology & Neurology

The Continuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I provides a comprehensive, evidence-based educational update on common and complex medical conditions encountered in family medicine, internal medicine, and outpatient primary care. Organized by Continuing Education Company, Inc. (CEC), this five-day medical education conference brings together experienced clinical faculty to review current diagnostic approaches, evolving therapeutic guidelines, newer medications, and practical strategies for improving patient outcomes. Held from March 31 to April 4, 2025, at Hammock Beach Golf Resort & Spa in Palm Coast, Florida, with in-person and live webcast attendance options, the conference focuses on clinically relevant developments across hepatology, infectious diseases, women's health, urogynecology, cardiology, hypertension, pharmacology, emergency medicine, vascular medicine, psychiatry, gastroenterology, and neurology. The CEC Primary Care Spring Conference 2025 curriculum examines elevated liver function tests, metabolic dysfunction-associated steatotic liver disease (MASLD), appropriate antibiotic prescribing, cellulitis, cardiovascular disease risk in midlife women, menopause, overactive bladder, postpartum pelvic symptoms, resistant hypertension, syncope, venous thromboembolism, new drug therapies, depression, psychiatric medication adverse effects, gastroesophageal reflux disease (GERD), dementia, and Alzheimer's disease. The program emphasizes integrating current research, diagnostic reasoning, clinical guidelines, and individualized patient management into everyday primary care practice. Through expert lectures, case-based education, and interactive pharmacology discussions, the conference supports practical continuing education for physicians and other healthcare professionals.

Course Details

  • Course: CEC 19th Annual Primary Care Spring Conference 2025
  • Official Event: 19th Annual Primary Care Spring Conference – Session I
  • Organizer: Continuing Education Company, Inc. (CEC)
  • Dates: March 31 – April 4, 2025
  • Location: Palm Coast, Florida, USA
  • Venue: Hammock Beach Golf Resort & Spa
  • Official Format: In-Person and Live Streaming Webcast
  • Duration: Five Days
  • Educational Schedule: 7:55 AM – 12:15 PM Eastern Time
  • Scheduled Educational Content: 20 Hours
  • Primary Specialty: Family Medicine / Primary Care
  • Additional Focus: Internal Medicine, Hepatology, Infectious Diseases, Women's Health, Urology, Cardiology, Pharmacology, Psychiatry, Gastroenterology and Neurology
  • Language: English
  • Published Scientific Lectures: 19
  • Additional Educational Session: Pharmacology Expert Q&A
  • Official Conference CME: Up to 20 CME Credits, subject to provider requirements
  • MedicalAmboss Listed Format: Videos + Slides
The original conference offered continuing education credits to eligible registered attendees. Official credits, certificates, conference registration, and publisher platform access are not included with separately distributed MedicalAmboss files.

Target Audience

The program is intended for healthcare professionals involved in the diagnosis, treatment, and long-term management of patients in outpatient and primary care settings. The target audience includes:
  • Primary Care Physicians
  • Family Medicine Physicians
  • Internal Medicine Physicians
  • General Practitioners
  • Hospitalists
  • Hepatologists
  • Gastroenterologists
  • Infectious Disease Specialists
  • Cardiologists
  • Gynecologists
  • Obstetricians and Gynecologists
  • Urologists
  • Urogynecologists
  • Emergency Medicine Physicians
  • Hematologists
  • Pulmonologists
  • Psychiatrists
  • Neurologists
  • Clinical Pharmacists
  • Physician Assistants
  • Nurse Practitioners
  • Advanced Practice Providers
  • Medical Residents
  • Clinical Fellows
  • Other Healthcare Professionals Involved in Primary Care
The conference is particularly relevant to clinicians seeking practical updates on chronic disease management, preventive medicine, medication safety, women's health, and evidence-based outpatient care.

Program Overview

Primary care clinicians routinely evaluate patients with multiple medical conditions requiring accurate diagnosis, appropriate investigation, and individualized treatment. The 19th Annual Primary Care Spring Conference 2025 – Session I addresses important changes in medical practice through focused specialty presentations and practical clinical reviews. The curriculum covers:
  • Elevated Liver Function Tests
  • Abnormal Liver Enzymes
  • MASLD
  • Antibiotic Stewardship
  • Common Outpatient Infections
  • Cellulitis
  • Cardiovascular Risk in Midlife Women
  • Menopause Management
  • Vasomotor Symptoms
  • Genitourinary Syndrome of Menopause
  • Overactive Bladder
  • Postpartum Pelvic Symptoms
  • Hypertension
  • Resistant Hypertension
  • New Drug Therapies
  • Clinical Pharmacology
  • Syncope
  • Venous Thromboembolism
  • D-Dimer Testing
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Depression
  • Antidepressant Therapy
  • Psychiatric Medication Adverse Effects
  • GERD
  • Extraesophageal Reflux
  • Dementia
  • Alzheimer's Disease
  • Evidence-Based Primary Care
  • Clinical Decision-Making
The program integrates clinical assessment, medical management, risk reduction, preventive care, and current treatment recommendations.

Learning Objectives

As a result of participating in the original conference, learners should be better able to:
  1. Assess and provide patients with accurate diagnoses and optimal care for a broad range of disorders commonly seen in primary care.
  2. Utilize current clinical guidelines in the diagnosis and management of frequently encountered therapeutic problems.
  3. Formulate comprehensive evidence-based interventions and treatment strategies to reduce modifiable risk factors and improve long-term patient outcomes.
  4. Evaluate elevated liver function tests and recognize metabolic dysfunction-associated steatotic liver disease.
  5. Apply evidence-based approaches to antibiotic selection and the management of common outpatient infections, including cellulitis.
  6. Assess cardiovascular risk in midlife women and review management strategies for menopausal symptoms.
  7. Evaluate overactive bladder and postpartum pelvic symptoms encountered in primary care.
  8. Apply contemporary recommendations to hypertension assessment and management, including resistant hypertension.
  9. Review emerging pharmacological treatments and recognize important medication safety considerations.
  10. Develop appropriate diagnostic approaches to syncope and suspected venous thromboembolism.
  11. Evaluate treatment options for depression and recognize adverse effects associated with psychiatric medications.
  12. Review diagnostic and treatment strategies for GERD and extraesophageal reflux.
  13. Recognize cognitive impairment, evaluate suspected dementia, and consider appropriate management of Alzheimer's disease.
The first three objectives reflect the organizer's general conference objectives. The remaining objectives elaborate on the published Session I lecture topics.

Official Program Topics

Day 1 – Monday, March 31, 2025

Conference Announcements

7:55 AM – 8:00 AM Faculty: W. Ejnes, CHCP Opening announcements and orientation to the educational program.

Session I – Hepatology

Boot Camp for Elevated Liver Function Tests

8:00 AM – 9:00 AM Faculty: P. Buch, MD This session examines the clinical evaluation of abnormal liver function tests, a frequently encountered issue in primary care and internal medicine. Important clinical considerations include:
  • Elevated Liver Enzymes
  • Abnormal Aminotransferases
  • Hepatocellular Injury
  • Cholestatic Liver Test Patterns
  • Clinical History
  • Medication-Related Liver Injury
  • Alcohol-Associated Liver Disease
  • Viral Hepatitis
  • Metabolic Liver Disease
  • Diagnostic Laboratory Testing
  • Imaging Considerations
  • Differential Diagnosis
  • Hepatology Referral
The educational focus is on developing a systematic approach to abnormal liver test results and selecting appropriate investigations.

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

9:00 AM – 10:00 AM Faculty: P. Buch, MD This presentation reviews metabolic dysfunction-associated steatotic liver disease and its relevance to modern primary care. Important topics include:
  • MASLD
  • Metabolic Risk Factors
  • Obesity
  • Type 2 Diabetes
  • Insulin Resistance
  • Hepatic Steatosis
  • Liver Fibrosis
  • Noninvasive Liver Assessment
  • Cardiometabolic Risk
  • Lifestyle Management
  • Weight Reduction
  • Clinical Monitoring
  • Referral Considerations
The session addresses current clinical concepts in the recognition and management of metabolic liver disease.

Session II – Infectious Diseases

More Head to Toe Antibiotics: Treatment Decisions for Common Outpatient Infections

10:15 AM – 11:15 AM Faculty: A. Urban, MD This presentation examines antibiotic treatment decisions for common infections encountered in outpatient clinical practice. Important considerations include:
  • Common Outpatient Infections
  • Antibiotic Selection
  • Antimicrobial Stewardship
  • Bacterial Infections
  • Diagnostic Assessment
  • Empiric Therapy
  • Antibiotic Resistance
  • Treatment Duration
  • Medication Allergies
  • Patient-Specific Risk Factors
  • Avoiding Unnecessary Antibiotic Use
The session emphasizes responsible prescribing and evidence-based antimicrobial management.

Cellulitis in Adults: Improving Care and Calming a Red Hot Literature

11:15 AM – 12:15 PM Faculty: A. Urban, MD This session reviews current approaches to diagnosing and managing cellulitis in adult patients. Important topics include:
  • Cellulitis
  • Skin and Soft Tissue Infections
  • Clinical Presentation
  • Differential Diagnosis
  • Erysipelas
  • Abscess Considerations
  • Antibiotic Therapy
  • MRSA Risk Assessment
  • Treatment Selection
  • Outpatient Management
  • Treatment Response
  • Indications for Hospital Evaluation
The presentation supports practical decision-making for adults presenting with suspected bacterial skin infections. 12:15 PM – Day 1 Adjournment

Day 2 – Tuesday, April 1, 2025

Conference Announcements

7:55 AM – 8:00 AM Faculty: W. Ejnes, CHCP

Session III – Women's Cardiovascular Health

Targeting Women at Risk of CVD at Midlife: A Challenge to the Physician

8:00 AM – 9:00 AM Faculty: C. Shufelt, MD This presentation examines cardiovascular disease risk assessment and prevention in midlife women. Important considerations include:
  • Cardiovascular Disease in Women
  • Midlife Cardiovascular Risk
  • Hormonal Transitions
  • Menopause
  • Traditional Cardiovascular Risk Factors
  • Female-Specific Risk Factors
  • Hypertension
  • Dyslipidemia
  • Metabolic Health
  • Preventive Screening
  • Risk Reduction
  • Lifestyle Interventions
  • Individualized Cardiovascular Care
The session emphasizes recognizing cardiovascular risk factors that may be overlooked during routine primary care assessment.

Management of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows

9:00 AM – 10:00 AM Faculty: C. Shufelt, MD This session reviews management of menopausal symptoms and genitourinary syndrome of menopause. Important topics include:
  • Menopause
  • Vasomotor Symptoms
  • Hot Flashes
  • Night Sweats
  • Genitourinary Syndrome of Menopause
  • Vaginal Dryness
  • Genitourinary Symptoms
  • Hormone Therapy
  • Nonhormonal Treatment Options
  • Treatment Safety
  • Patient Preferences
  • Evidence-Based Management
The presentation emphasizes appropriate treatment selection based on clinical evidence and patient-specific circumstances.

Session IV – Urology and Urogynecology

How to Address Overactive Bladder in Primary Care

10:15 AM – 11:15 AM Faculty: L. Rogo-Gupta, MD This presentation reviews evaluation and management of overactive bladder in primary care settings. Important considerations include:
  • Overactive Bladder
  • Urinary Urgency
  • Urinary Frequency
  • Urge Incontinence
  • Clinical Evaluation
  • Differential Diagnosis
  • Behavioral Interventions
  • Bladder Training
  • Pelvic Floor Therapy
  • Pharmacological Options
  • Treatment-Related Adverse Effects
  • Referral to Urogynecology
The session emphasizes practical management approaches relevant to outpatient medicine.

How to Address Pelvic Symptoms in Postpartum Patients Transitioning Back to Primary Care

11:15 AM – 12:15 PM Faculty: L. Rogo-Gupta, MD This session examines pelvic symptoms affecting postpartum patients as they transition from obstetric care to primary care follow-up. Important topics include:
  • Postpartum Pelvic Health
  • Pelvic Floor Dysfunction
  • Urinary Incontinence
  • Pelvic Symptoms
  • Postpartum Recovery
  • Clinical Assessment
  • Pelvic Floor Rehabilitation
  • Symptom Recognition
  • Patient Counseling
  • Appropriate Referral
  • Continuity of Care
The presentation emphasizes coordination between obstetric, primary care, and urogynecology services. 12:15 PM – Day 2 Adjournment

Day 3 – Wednesday, April 2, 2025

Conference Announcements

7:55 AM – 8:00 AM Faculty: W. Ejnes, CHCP

Session V – Cardiology and Hypertension

Controversies in Hypertension: Testing What You Know

8:00 AM – 9:00 AM Faculty: J. Basile, MD This presentation reviews important controversies and evolving recommendations in hypertension management. Important considerations include:
  • Hypertension Diagnosis
  • Blood Pressure Measurement
  • Cardiovascular Risk Assessment
  • Clinical Guidelines
  • Treatment Thresholds
  • Blood Pressure Targets
  • Antihypertensive Therapy
  • Patient-Specific Treatment
  • Clinical Evidence
  • Risk-Benefit Assessment
The session examines areas where clinicians must interpret research and apply treatment recommendations to individual patients.

Resistant Hypertension: An Update

9:00 AM – 10:00 AM Faculty: J. Basile, MD This presentation reviews the assessment and treatment of resistant hypertension. Important clinical topics include:
  • Resistant Hypertension
  • Apparent Treatment Resistance
  • Medication Adherence
  • Blood Pressure Monitoring
  • Secondary Hypertension
  • Primary Aldosteronism
  • Medication Optimization
  • Combination Therapy
  • Cardiovascular Risk
  • Lifestyle Factors
  • Specialist Referral
The educational emphasis is on systematic evaluation and appropriate management of persistent blood pressure elevation.

Session VI – Clinical Pharmacology

New Drug Update

10:15 AM – 11:15 AM Faculty: W. Weart, PharmD This presentation reviews recent developments in pharmacological therapies relevant to primary care. Important considerations include:
  • Newly Available Medications
  • Therapeutic Advances
  • Drug Mechanisms
  • Clinical Indications
  • Medication Safety
  • Contraindications
  • Adverse Effects
  • Drug Interactions
  • Prescribing Considerations
  • Evidence-Based Pharmacotherapy
The session emphasizes the practical interpretation of new medication evidence.

Ask the Expert: Pharmacology Q&A

11:15 AM – 12:15 PM Faculty: W. Weart, PharmD This interactive session addresses clinical pharmacology questions arising in everyday patient care. Relevant themes include:
  • Medication Selection
  • Drug Interactions
  • Adverse Effects
  • Clinical Prescribing
  • Therapeutic Alternatives
  • Medication Safety
  • Patient-Specific Treatment Decisions
12:15 PM – Day 3 Adjournment

Day 4 – Thursday, April 3, 2025

Conference Announcements

7:55 AM – 8:00 AM Faculty: W. Ejnes, CHCP

Session VII – Emergency and Vascular Medicine

Syncope: What to do When the Lights Go Out

8:00 AM – 9:00 AM Faculty: R. Dachs, MD This presentation reviews the evaluation of syncope and transient loss of consciousness. Important considerations include:
  • Syncope
  • Transient Loss of Consciousness
  • Vasovagal Syncope
  • Orthostatic Hypotension
  • Cardiac Syncope
  • Arrhythmias
  • Clinical History
  • Physical Examination
  • Electrocardiography
  • Risk Stratification
  • Diagnostic Testing
  • Indications for Emergency Evaluation
The session emphasizes distinguishing benign presentations from potentially serious causes.

Venous Thromboembolism and the D-Dimer: 1) The Case of the Swollen Calf and 2) The Case of Pleuritic Chest Pain

9:00 AM – 10:00 AM Faculty: R. Dachs, MD This presentation examines diagnostic decision-making in patients with suspected venous thromboembolism. The lecture uses two clinically relevant presentations: The Case of the Swollen Calf Relevant considerations include:
  • Deep Vein Thrombosis
  • Leg Swelling
  • Clinical Probability
  • D-Dimer Testing
  • Venous Ultrasonography
  • Differential Diagnosis
The Case of Pleuritic Chest Pain Relevant considerations include:
  • Pulmonary Embolism
  • Pleuritic Chest Pain
  • Clinical Risk Assessment
  • D-Dimer Interpretation
  • Diagnostic Imaging
  • Emergency Evaluation
  • Anticoagulation Considerations
The session emphasizes appropriate use of clinical probability assessment and diagnostic testing.

Session VIII – Psychiatry and Behavioral Health

The Treatment of Depression: SSRIs and Beyond

10:15 AM – 11:15 AM Faculty: T. Heinrich, MD This presentation reviews current approaches to depression treatment in primary care. Important topics include:
  • Major Depressive Disorder
  • Depression Screening
  • Clinical Assessment
  • Selective Serotonin Reuptake Inhibitors
  • Other Antidepressant Classes
  • Treatment Selection
  • Treatment Response
  • Medication Adjustment
  • Psychotherapy
  • Treatment-Resistant Depression
  • Patient Safety
  • Long-Term Management
The session emphasizes individualized treatment planning and appropriate monitoring.

Side Effects of Psychiatric Medications

11:15 AM – 12:15 PM Faculty: T. Heinrich, MD This session examines adverse effects associated with commonly prescribed psychiatric medications. Important considerations include:
  • Antidepressant Adverse Effects
  • Antipsychotic Medication Effects
  • Sedation
  • Metabolic Side Effects
  • Sexual Dysfunction
  • Drug Interactions
  • Medication Monitoring
  • Treatment Adherence
  • Risk-Benefit Assessment
  • Medication Safety
The presentation supports safer prescribing and recognition of treatment-related complications. 12:15 PM – Day 4 Adjournment

Day 5 – Friday, April 4, 2025

Conference Announcements

7:55 AM – 8:00 AM Faculty: W. Ejnes, CHCP

Session IX – Gastroenterology

GERD and Extraesophageal GERD: How to Test and Treat?

8:00 AM – 10:00 AM Faculty: M. Vaezi, MD This extended presentation reviews gastroesophageal reflux disease and extraesophageal manifestations of reflux. Important topics include:
  • Gastroesophageal Reflux Disease
  • GERD Symptoms
  • Heartburn
  • Regurgitation
  • Extraesophageal Reflux
  • Chronic Cough
  • Laryngopharyngeal Symptoms
  • Diagnostic Evaluation
  • Upper Endoscopy
  • Ambulatory Reflux Testing
  • Proton Pump Inhibitors
  • Nonpharmacological Management
  • Treatment Selection
  • Refractory Symptoms
  • Gastroenterology Referral
The session emphasizes evidence-based diagnostic testing and appropriate therapy.

Session X – Neurology and Cognitive Disorders

A True Clinic-based Approach to Dementia

10:15 AM – 11:15 AM Faculty: G. Day, MD This presentation reviews practical approaches to diagnosing cognitive impairment and dementia in primary care. Important clinical considerations include:
  • Cognitive Impairment
  • Dementia
  • Memory Complaints
  • Clinical History
  • Cognitive Screening
  • Neurological Examination
  • Differential Diagnosis
  • Reversible Contributors
  • Diagnostic Investigations
  • Patient Safety
  • Specialist Referral
  • Caregiver Support
The session emphasizes structured outpatient evaluation of patients with suspected cognitive disorders.

Clinical Findings and Approach to Management in Alzheimer Disease

11:15 AM – 12:15 PM Faculty: G. Day, MD This presentation examines Alzheimer's disease diagnosis and management. Important topics include:
  • Alzheimer's Disease
  • Cognitive Decline
  • Memory Impairment
  • Clinical Presentation
  • Diagnostic Evaluation
  • Biomarkers
  • Disease Severity
  • Symptomatic Treatment
  • Disease-Modifying Treatment Considerations
  • Medication Safety
  • Functional Assessment
  • Caregiver Education
  • Long-Term Management
The session reviews important clinical aspects of Alzheimer's disease in primary care. 12:15 PM – Conference Adjournment

Major Topics Covered

  • Continuing Education Company Primary Care Spring Conference 2025
  • CEC 19th Annual Primary Care Spring Conference
  • Family Medicine
  • Internal Medicine
  • Primary Care
  • Hepatology
  • Elevated Liver Function Tests
  • Abnormal Liver Enzymes
  • MASLD
  • Metabolic Liver Disease
  • Infectious Diseases
  • Antibiotic Stewardship
  • Outpatient Infection Management
  • Cellulitis
  • Women's Cardiovascular Health
  • Cardiovascular Risk Assessment
  • Menopause
  • Vasomotor Symptoms
  • Genitourinary Syndrome of Menopause
  • Urogynecology
  • Overactive Bladder
  • Postpartum Pelvic Symptoms
  • Hypertension
  • Resistant Hypertension
  • Clinical Pharmacology
  • New Drug Therapies
  • Medication Safety
  • Syncope
  • Venous Thromboembolism
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • D-Dimer Testing
  • Depression
  • Antidepressants
  • Psychiatric Medication Side Effects
  • GERD
  • Extraesophageal Reflux
  • Dementia
  • Alzheimer's Disease
  • Cognitive Assessment
  • Evidence-Based Medicine
  • Preventive Primary Care

Hepatology and Metabolic Liver Disease

Abnormal liver function tests and metabolic liver disease are frequently encountered in primary care. The conference includes dedicated presentations covering:
  • Elevated Liver Enzymes
  • Diagnostic Evaluation
  • Liver Disease Risk Factors
  • MASLD
  • Metabolic Dysfunction
  • Fibrosis Assessment
  • Liver Disease Monitoring
  • Appropriate Referral
These sessions support structured investigation and evidence-based management of common liver conditions.

Infectious Diseases and Antibiotic Stewardship

Responsible antibiotic prescribing is an important component of primary care practice. The curriculum addresses the management of common outpatient infections and adult cellulitis. Important considerations include antimicrobial resistance, treatment selection, infection severity, patient-specific risk factors, and avoiding unnecessary antibiotic exposure.

Women's Health and Midlife Cardiovascular Risk

Midlife represents an important period for preventive healthcare in women. The program examines cardiovascular risk, menopause, genitourinary symptoms, overactive bladder, and postpartum pelvic health. The educational emphasis is on recognizing symptoms, applying current evidence, and coordinating appropriate patient care.

Hypertension and Cardiovascular Medicine

Hypertension remains an important contributor to cardiovascular morbidity. The conference includes focused sessions on controversies in hypertension treatment and resistant hypertension. Relevant themes include blood pressure assessment, cardiovascular risk, secondary causes, medication adherence, treatment selection, and individualized management.

Pharmacology and Medication Safety

New medications and changing therapeutic recommendations present ongoing challenges for primary care clinicians. The conference includes a new drug update and an interactive pharmacology session. These sessions emphasize understanding clinical indications, medication safety, interactions, adverse effects, and evidence-based prescribing decisions.

Syncope and Venous Thromboembolism

Syncope, leg swelling, and pleuritic chest pain may require evaluation for serious cardiovascular or thromboembolic conditions. The curriculum examines:
  • Clinical Risk Assessment
  • Differential Diagnosis
  • Electrocardiography
  • D-Dimer Testing
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Diagnostic Imaging
  • Appropriate Referral
These topics support accurate clinical assessment and timely identification of potentially serious disease.

Depression and Psychiatric Medication Management

Depression and psychiatric medication-related complications are frequently encountered in general medical practice. The program reviews antidepressant treatment strategies, medication safety, and adverse effects. The educational focus supports appropriate therapy selection, patient monitoring, and individualized management.

GERD and Extraesophageal Reflux

Gastroesophageal reflux disease is a common gastrointestinal condition. The course includes an extended presentation reviewing diagnosis and treatment of GERD and extraesophageal reflux. Important considerations include symptom assessment, diagnostic testing, medical management, treatment response, and recognition of patients requiring additional gastroenterological evaluation.

Dementia and Alzheimer's Disease

Primary care physicians play an important role in the recognition and ongoing care of patients with cognitive disorders. The curriculum includes two dedicated sessions addressing clinical assessment of dementia and Alzheimer's disease management. Important topics include cognitive screening, differential diagnosis, diagnostic evaluation, clinical management, caregiver education, and long-term follow-up.

Evidence-Based Clinical Decision-Making

The CEC 19th Annual Primary Care Spring Conference 2025 emphasizes translating evidence and practice recommendations into everyday medical care. Important clinical responsibilities include:
  • Recognizing Important Symptoms
  • Performing Appropriate Clinical Assessments
  • Establishing Differential Diagnoses
  • Selecting Diagnostic Tests
  • Applying Current Guidelines
  • Choosing Appropriate Treatments
  • Managing Medication Risks
  • Reducing Modifiable Risk Factors
  • Coordinating Specialist Referrals
  • Supporting Long-Term Patient Outcomes
The program integrates multiple specialties into a practical primary care educational framework.

Official Faculty

The Session I agenda identifies the following presenters:
  • W. Ejnes, CHCP — Conference Announcements
  • P. Buch, MD — Hepatology
  • A. Urban, MD — Infectious Diseases
  • C. Shufelt, MD — Women's Health and Cardiovascular Prevention
  • L. Rogo-Gupta, MD — Urogynecology
  • J. Basile, MD — Hypertension
  • W. Weart, PharmD — Clinical Pharmacology
  • R. Dachs, MD — Emergency and Vascular Medicine
  • T. Heinrich, MD — Psychiatry
  • M. Vaezi, MD — Gastroenterology
  • G. Day, MD — Neurology and Dementia
These faculty members cover a broad range of clinically important subjects relevant to internal medicine and outpatient primary care.

Continuing Medical Education

Continuing Education Company advertised up to 20 CME credits for the original 2025 Primary Care Spring Conference. The original educational program was delivered through in-person and live webcast participation. Official eligibility, continuing education credits, documentation, and certificates were governed by CEC's participation and completion requirements.

Important CME Notice

Purchasing separately distributed educational materials through MedicalAmboss does not provide:
  • Official CEC CME Credits
  • Official Completion Certificates
  • Conference Registration
  • Live Conference Attendance
  • Publisher Webcast Access
  • Official CEC Online Accounts
  • Publisher Memberships
  • Publisher-Hosted Educational Extras

Why This Course Is Relevant

The Continuing Education Company 19th Annual Primary Care Spring Conference 2025 – Session I provides a multidisciplinary review of medical conditions commonly encountered by primary care physicians. The curriculum addresses:
  • Liver Disease
  • Outpatient Infections
  • Cellulitis
  • Cardiovascular Risk in Women
  • Menopause
  • Urinary Symptoms
  • Hypertension
  • Medication Updates
  • Syncope
  • Venous Thromboembolism
  • Depression
  • GERD
  • Dementia
  • Alzheimer's Disease
Its integration of diagnostic updates, therapeutic guidance, pharmacology, preventive medicine, and clinical decision-making makes it particularly relevant to internists, family physicians, and other healthcare professionals seeking continuing education in primary care.

Official Program Reference and MedicalAmboss Purchase Scope

Continuing Education Company: https://www.cmemeeting.org/ MedicalAmboss Product: https://medicalamboss.com/product/cec-19th-annual-primary-care-spring-conference-2025/ The course information and lecture titles are based on the published 2025 Session I agenda. The original event program does not independently verify the inventory, runtime, or completeness of files included in the MedicalAmboss product. MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.

Short Description

CEC 19th Annual Primary Care Spring Conference 2025 – Session I provides a comprehensive, evidence-based educational update in family medicine, internal medicine, hepatology, infectious diseases, women's health, cardiology, clinical pharmacology, psychiatry, gastroenterology, and neurology. Held March 31 – April 4, 2025, in Palm Coast, Florida, the original conference features expert clinical presentations on elevated liver function tests, MASLD, antibiotics, cellulitis, menopause, overactive bladder, hypertension, syncope, VTE, depression, GERD, dementia, and Alzheimer's disease.

Topics (Session I)

MONDAY, March 31, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Boot Camp for Elevated Liver Function Tests — P. Buch, MD

  • 9:00 am – 10:00 am: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) — P. Buch, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: More Head to Toes Antibiotics: Treatment Decisions for Common Outpatient Infections — A. Urban, MD

  • 11:15 am – 12:15 pm: Cellulitis in Adults: Improving Care and Calming Red-Hot Literature — A. Urban, MD

TUESDAY, April 1, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Targeting Women at Risk of CVD at Midlife: A Challenge to the Physician — C. Shufelt, MD

  • 9:00 am – 10:00 am: Management of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows — C. Shufelt, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: How to Address Overactive Bladder in Primary Care — L. Rogo-Gupta, MD

  • 11:15 am – 12:15 pm: How to Address Pelvic Symptoms in Postpartum Patients Transitioning Back to Primary Care — L. Rogo-Gupta, MD

WEDNESDAY, April 2, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Controversies in Hypertension: Testing What You Know — J. Basile, MD

  • 9:00 am – 10:00 am: Resistant Hypertension: An Update — J. Basile, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: New Drug Update — W. Weart, PharmD

  • 11:15 am – 12:15 pm: Ask the Expert: Pharmacology Q&A — W. Weart, PharmD

THURSDAY, April 3, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Syncope: What to Do When the Lights Go Out? — R. Dachs, MD

  • 9:00 am – 10:00 am: Venous Thromboembolism and the D-Dimer: 1) The Case of the Swollen Calf and 2) The Case of Pleuritic Chest Pain — R. Dachs, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: A Primary Care Perspective on the Treatment of Depression: SSRIs and Beyond — T. Heinrich, MD

  • 11:15 am – 12:15 pm: Side Effects of Psychiatric Medications — T. Heinrich, MD

FRIDAY, April 4, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 10:00 am: GERD and Extraesophageal GERD: How to Test and Treat? — M. Vaezi, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: A True Clinic-based Approach to Dementia — G. Day, MD

  • 11:15 am – 12:15 pm: Clinical Findings and Approach to Management in Alzheimer Disease — G. Day, MD

19TH ANNUAL PRIMARY CARE SPRING CONFERENCE 2025 – SESSION II

  • Conference Title: 19th Annual Primary Care Spring Conference – Session II

  • Organizer: Continuing Education Company, Inc. (CEC)

  • Dates: April 14–18, 2025

  • Location: Hammock Beach Golf Resort & Spa, Palm Coast, Florida, USA (In-Person and Live Streaming Webcast)

  • Description: The 19th Annual Primary Care Spring Conference (Session II), organized by the Continuing Education Company (CEC), is a 5-day live and virtual event held at the Hammock Beach Golf Resort & Spa in Palm Coast, Florida. The curriculum provides evidence-based clinical updates across Hepatology, Hypertension, Women’s Health & Menopause, Cardiovascular-Kidney-Metabolic (CKM) Syndrome, Obesity Medicine, Psychiatry, Gastroenterology, Emergency/Vascular Medicine, Neurology (Migraine, Dementia, Alzheimer’s Disease), and Clinical Pharmacology.

Learning Objectives

As a result of this conference, participants will be able to:

  • Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.

  • Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.

  • Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long-term outcomes.

  • Apply practical diagnostic and management strategies for elevated liver function tests, metabolic dysfunction-associated steatotic liver disease (MASLD), and GERD/extraesophageal GERD.

  • Manage complex cardiovascular and metabolic conditions, including resistant hypertension, midlife CVD risk in women, Cardiovascular-Kidney-Metabolic (CKM) syndrome, and obesity-related cardiovascular disease.

  • Evaluate and treat depression, psychiatric medication side effects, migraine headaches, dementia, and Alzheimer’s disease in the outpatient setting.

  • Utilize evidence-based diagnostic pathways for syncope, venous thromboembolism (VTE), and newly approved pharmacological agents.

Target Audience

This course is intended for primary care physicians, family medicine physicians, internists, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals involved in outpatient and primary care medicine.

Best for Primary Care Physicians, Family Physicians, Internists, Hepatologists, Gastroenterologists, Endocrinologists, Cardiologists, Nephrologists, Gynecologists, Obstetricians and Gynecologists (OB-GYNs), Psychiatrists, Emergency Medicine Physicians, Hematologists, Pulmonologists, and Neurologists.

Topics (Session II)

MONDAY, April 14, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Boot Camp for Elevated Liver Function Tests: A Practical Approach for Primary Care — F. Pasquel, MD

  • 9:00 am – 10:00 am: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) — F. Pasquel, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: Controversies in Hypertension: Testing What You Know — J. Basile, MD

  • 11:15 am – 12:15 pm: Resistant Hypertension: An Update — J. Basile, MD

TUESDAY, April 15, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Targeting Women at Risk of CVD at Midlife: A Challenge to the Physician — C. Shufelt, MD

  • 9:00 am – 10:00 am: Management of the Vasomotor Symptoms and the Genitourinary Syndrome of Menopause, What the Evidence Shows — C. Shufelt, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Evolving Priorities for Cardiovascular Prevention and Management — C. Ndumele, MD

  • 11:15 am – 12:15 pm: Addressing the Link Between Obesity and Cardiovascular Disease — C. Ndumele, MD

WEDNESDAY, April 16, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: The Treatment of Depression: SSRIs and Beyond — T. Heinrich, MD

  • 9:00 am – 10:00 am: Side Effects of Psychiatric Medications — T. Heinrich, MD

  • 10:00 am: BREAK

  • 10:15 am – 12:15 pm: GERD and Extraesophageal GERD: How to Test and Treat? — M. Vaezi, MD

THURSDAY, April 17, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: Syncope: What to do When the Lights Go Out — R. Dachs, MD

  • 9:00 am – 10:00 am: Venous Thromboembolism and the D-Dimer: The Case of the Swollen Calf and the Case of Pleuritic Chest Pain — R. Dachs, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: Diagnosis of Migraine — J. Ailani, MD

  • 11:15 am – 12:15 pm: Migraine State of the Art — J. Ailani, MD

FRIDAY, April 18, 2025

  • 7:55 am – 8:00 am: Conference Announcements — W. Ejnes, CHCP

  • 8:00 am – 9:00 am: A True Clinic-based Approach to Dementia — G. Day, MD

  • 9:00 am – 10:00 am: Clinical Findings and Approach to Management in Alzheimer Disease — G. Day, MD

  • 10:00 am: BREAK

  • 10:15 am – 11:15 am: New Drug Update — C. Weart, PharmD

  • 11:15 am – 12:15 pm: Ask the Expert: Pharmacology Q&A — C. Weart, PharmD

You may also like